SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for HEALTHEQUITY, INC. (HQY) (CIK 0001428336) (HQY) — Aug 2, 2016

HEALTHEQUITY, INC. (HQY) (CIK 0001428336)
Date: Aug. 2, 2016 · CIK: 0001428336 · Accession: 0000000000-16-086800

Regulatory Compliance Financial Reporting Internal Controls

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
January 31, 2016
Author
/s/ William H. Thompson
Form
UPLOAD
Company
HEALTHEQUITY, INC. (HQY) (CIK 0001428336)

Letter

Mail Stop 3561 August 2 , 2016 Mr. Jon Kessler President and Chief Executive Officer HealthEquity, Inc. 15 West Scenic Pointe Drive, Suite 100 Draper, Utah 84020

Re: HealthEquity, Inc. Form 10-K for the Fiscal Year Ended January 31, 2016 Filed March 31, 2016 File No. 1 -36568

Dear Mr. Kessler :

We have completed our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ William H. Thompson

Show Raw Text
Mail Stop 3561
August 2 , 2016

Mr. Jon Kessler
President and Chief Executive Officer
HealthEquity, Inc.
15 West Scenic Pointe Drive, Suite 100
Draper, Utah 84020

Re: HealthEquity, Inc.
 Form 10-K for the Fiscal Year Ended January 31, 2016
Filed March 31, 2016
File No. 1 -36568

Dear Mr. Kessler :

We have completed our review of your filing .  We remind you that our comments or
changes to disclosure in response to our comments do not foreclose the Commission from taking
any action with respect to the company or the filing and the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any person under the
federal securities laws of the  United States.  We urge all persons who are responsible for the
accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,

 /s/ William H. Thompson

William H. Thompson
Accounting Branch Chief
Office of Consumer Products

cc: Del Ladd
 Associate General Counsel